Comstock Announces Strategic Partnership with EFT Comstock has recently revealed a significant strategic partnership between its subsidiary, Comstock IP Holdings …
Read More »7 Flaws in Ban on Mifepristone Science
Judge Matthew Kacsmaryk’s recent decision to roll back the FDA’s authorization of mifepristone, the first drug in the standard two-part medication abortion protocol, is an unprecedented judicial act. The ruling directly opposes the scientific judgment of the FDA and demonstrates illogical thinking, ignored context, and unscientific findings. Kacsmaryk uses the language of the anti-abortion movement over scientific terminology, claims that …
Read More »